These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19648383)

  • 41. Real-life long-term omalizumab therapy in children with severe allergic asthma.
    Deschildre A; Marguet C; Langlois C; Pin I; Rittié JL; Derelle J; Abou Taam R; Fayon M; Brouard J; Dubus JC; Siret D; Weiss L; Pouessel G; Beghin L; Just J
    Eur Respir J; 2015 Sep; 46(3):856-9. PubMed ID: 26022964
    [No Abstract]   [Full Text] [Related]  

  • 42. What is the problem with asthma care for children?
    Weinberger MM
    Arch Pediatr Adolesc Med; 2011 May; 165(5):473-5. PubMed ID: 21536964
    [No Abstract]   [Full Text] [Related]  

  • 43. Asthma in pregnancy.
    Dombrowski MP; Schatz M
    Clin Obstet Gynecol; 2010 Jun; 53(2):301-10. PubMed ID: 20436305
    [TBL] [Abstract][Full Text] [Related]  

  • 44. How Much Do We Know About Clinical Response and Remission to Add-On Biologics in Severe Asthma in a Real-World Setting.
    Wu WW; Wang G
    Chest; 2024 May; 165(5):e157-e158. PubMed ID: 38724156
    [No Abstract]   [Full Text] [Related]  

  • 45. Airway remodeling: therapeutic target or not?
    Szefler SJ
    Am J Respir Crit Care Med; 2005 Apr; 171(7):672-3. PubMed ID: 15790863
    [No Abstract]   [Full Text] [Related]  

  • 46. Symptoms, lung function, and perception of asthma control: an exploration into the heterogeneity of the asthma control construct.
    Janssens T; Verleden G; Van den Bergh O
    J Asthma; 2012 Feb; 49(1):63-9. PubMed ID: 22121947
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Classification of asthma severity: Severe/not severe asthma or mild/moderate/severe asthma?
    Yılmaz İ; Paçacı Çetin G; Arslan B
    Tuberk Toraks; 2022 Sep; 70(3):300-301. PubMed ID: 36164956
    [No Abstract]   [Full Text] [Related]  

  • 48. The Tempest: Difficult to Control Asthma in Adolescence.
    Burg GT; Covar R; Oland AA; Guilbert TW
    J Allergy Clin Immunol Pract; 2018; 6(3):738-748. PubMed ID: 29747981
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Single-Dose Dexamethasone an Option for Acute Adult Asthma.
    Shaughnessy AF
    Am Fam Physician; 2017 Mar; 95(6):Online. PubMed ID: 28318206
    [No Abstract]   [Full Text] [Related]  

  • 50. Intravenous montelukast in acute asthma.
    Jalba MS
    Am J Respir Crit Care Med; 2004 Jan; 169(1):130; author reply 131. PubMed ID: 14695109
    [No Abstract]   [Full Text] [Related]  

  • 51. The adolescent with asthma: fostering adherence to optimize therapy.
    Jones BL; Kelly KJ
    Clin Pharmacol Ther; 2008 Dec; 84(6):749-53. PubMed ID: 18946465
    [No Abstract]   [Full Text] [Related]  

  • 52. Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma.
    Couillard S; Shrimanker R; Chaudhuri R; Mansur AH; McGarvey LP; Heaney LG; Fowler SJ; Bradding P; Pavord ID; Hinks TSC
    Am J Respir Crit Care Med; 2021 Sep; 204(6):731-734. PubMed ID: 34129808
    [No Abstract]   [Full Text] [Related]  

  • 53. Asthma in children. Optimising therapy.
    Massie J
    Aust Fam Physician; 1999 Feb; 28(2):107-11. PubMed ID: 10048246
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical significance and shortcoming of classification of asthma severity].
    Lin JT; Zhong NS
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Mar; 28(3):145-6. PubMed ID: 15854406
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of add-on therapy with NDC-052, an extract from Magnoliae Flos, in adult asthmatic patients receiving inhaled corticosteroids.
    Park CS; Kim TB; Lee JY; Park JY; Lee YC; Jeong SS; Lee YD; Cho YS; Moon HB
    Korean J Intern Med; 2012 Mar; 27(1):84-90. PubMed ID: 22403504
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute asthma in children: treatment in emergency.
    Pavone P; Longo MR; Taibi R; Nunnari G; Romano C; Passaniti E; Falsaperla R
    Eur Rev Med Pharmacol Sci; 2011 Jun; 15(6):711-6. PubMed ID: 21796876
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mepolizumab approved as add-on long-term therapy for severe asthma.
    Thompson CA
    Am J Health Syst Pharm; 2015 Dec; 72(24):2125. PubMed ID: 26637509
    [No Abstract]   [Full Text] [Related]  

  • 58. Severe refractory asthma: an update.
    Wener RR; Bel EH
    Eur Respir Rev; 2013 Sep; 22(129):227-35. PubMed ID: 23997049
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunological intervention with anti-immunoglobulin-E antibody to prevent asthma exacerbations.
    Chanez P
    Eur Respir J; 2001 Aug; 18(2):249-50. PubMed ID: 11529279
    [No Abstract]   [Full Text] [Related]  

  • 60. Omalizumab discontinuation in children with severe allergic asthma: An observational real-life study.
    Deschildre A; Roussel J; Drumez E; Abou-Taam R; Rames C; Le Roux P; Pouessel G; Scalbert M; Bonnel C; Mitha S; Boileau S; Mordacq C; Thumerelle C; Labreuche J; Lejeune S; Marguet C
    Allergy; 2019 May; 74(5):999-1003. PubMed ID: 30481388
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.